Step forward in the understanding of Ewing sarcoma
IDIBELL researchers identify key factors in Ewing’s sarcoma metastasis
Step forward in the understanding of Ewing sarcoma Read More »
Dr. Fernando Fernández Aranda and Dr. Esteve Fernández, distinguished with ICREA Academia grants to promote research
Two IDIBELL researchers receive financial support to consolidate and enhance the internationalization of their research
New perspectives on prostate cancer: the identification of dietary and microbial metabolites could be key in prevention
This large-scale nutrimetabolomic analysis, one of the most extensive to date, underscores the relevance of dietary factors and the gut microbiome in prostate cancer risk.
The study has been led by the Bellvitge Biomedical Research Institute (IDIBELL), the University of Barcelona and the CIBER on Frailty and Healthy Ageing (CIBERFES).
A multicenter clinical trial has evaluated the efficacy and safety of extended antibiotic infusion in febrile neutropenia
A Bellvitge research team has conducted a randomized clinical trial in hematological patients with febrile neutropenia to assess the efficacy of extended infusion of beta-lactam antibiotics
The results show that extended perfusion may be useful in combating some infections, but do not support the introduction of this technique into daily clinical practice for the empirical treatment of febrile neutropenia.
IDIBELL, Bellvitge Hospital and the Josep Carreras Institute discover a key mechanism in the recovery of kidney transplant function
They have described a cause why kidney progenitor cells sometimes can’t repair damaged tissues
The study has been published in the American Journal of Transplantation, the journal with the highest impact on transplantation
IDIBELL organizes the II Assembly of XarSMART
XarSMART plays the role of a valorization and transfer network, and works to increase the market value of Personalized Precision Medicine, digital health and biomedical data science projects.
IDIBELL organizes the II Assembly of XarSMART Read More »
An intellectually stimulating lifestyle is key to fighting Huntington’s disease
An intellectually stimulating lifestyle has been shown to reduce the severity of cognitive deficits and delay disease progression in Huntington’s disease patients. Now, a new study led by IDIBELL researchers shows that these positive effects may also have a direct transfer to motor and psychiatric domains of the disease, not only cognitive.
An intellectually stimulating lifestyle is key to fighting Huntington’s disease Read More »
New advances in research on metastasis in different types of melanoma
A team of researchers from IDIBELL presents two studies that expand knowledge about metastasis in melanoma.
They have managed to decipher, on the one hand, the role of PRRX1 in cancer progression and metastasis of cutaneous melanoma, as well as its prognostic value, and, secondly, the role of exosomes in the preparation of liver metastasis of uveal melanoma.
New advances in research on metastasis in different types of melanoma Read More »
Growth pattern in colon cancer liver metastases may influence response to immunotherapy
IDIBELL and ICO researchers demonstrate that the better prognosis of colon cancer with encapsulating liver metastases is due to the characteristics of the cellular microenvironment.
The study indicates that encapsulating metastases have an antitumor immunity that could be exploited using immunotherapies.
Growth pattern in colon cancer liver metastases may influence response to immunotherapy Read More »
An international study with the participation of IDIBELL shows that the drug semaglutide, for obesity and diabetes, protects the kidney in obese people with kidney disease
The novel results have been presented at the Kidney Week 2024 Congress of the American Society of Nephrology, in San Diego, and have been published simultaneously in the prestigious journal Nature Medicine. In Spain, 40% of the population is overweight, 22% of the population is obese and 3 out of 10 patients with chronic kidney disease suffer from obesity.